Table 1.
Study Characteristics Including Design, Number of Fractures Assessed, Quality Score as Determined by the MINORS Criteria, Level of Evidence, and Study Demographics.
| Author (year) | Design | N | Quality score | Level of evidence | Treatment: No. of fractures | Follow-up (average) | Gender (female/male) | Time ROM start |
|---|---|---|---|---|---|---|---|---|
| Abubeih et al 12 | Randomized prospective | 50 | 14/24 | II | ORIF: 50 | 8 weeks | 5/16 | 4 days |
| Ataker et al 18 | Prospective | 22 | 11/16 | IV | ORIF: 22 | 15.4 months | 8/14 | 1 week |
| Başar et al 2 | Retrospective | 22 | 16/24 | IV | ORIF: 22 | 19.2 months | 4/18 | 1 week |
| Brei-Thoma et al 6 | Retrospective | 29 | 11/16 | IV | ORIF: 29 | 10 months | 15/17 | 2-4 days |
| Desaldeleer-Le Sant et al 1 | Retrospective multicenter | 35 | 12/16 | III | CRPP: 26 ORIF: 9 |
N/A N/A |
28/59 | 1.7 weeks |
| El-Saeed et al 10 | Prospective randomized | 40 | 21/24 | II | CRPP: 20 ORIF: 20 |
6.5 months 7.2 months |
3/17 4/16 |
1 week |
| Faruqui et al 4 | Retrospective | 50 | 16/24 | III | CRPP: 50 | 8 months | N/A | 1 week |
| Kootstra et al 9 | Retrospective multicenter | 106 | 17/24 | IV | CRPP: 63 ORIF: 43 |
3.2 years 3.5 years |
30/33 19/24 |
4 weeks Variable |
| Köse et al 3 | Retrospective | 40 | 16/24 | IV | CRPP: 18 ORIF: 22 |
16 months 16 months |
8/10 1/21 |
1 week |
| Miller et al 19 | Prospective | 40 | 12/16 | III | ORIF: 40 | 12 weeks | 10/30 | 1 week |
| Robinson et al 5 | Retrospective | 42 | 17/24 | III | ORIF: 42 | 20 weeks | 19/23 | UNK |
| Sadek 11 | Prospective randomized | 26 | 16/24 | II | CRPP: 26 | 22.8 months | 5/21 | 2 days |
| Saied and Sabet Jahromi 13 | Prospective | 61 | 14/24 | III | CRPP: 61 | 6 months | 11/50 | 2 days |
| Shewring et al 20 | Prospective | 113 | 9/16 | IV | CRPP: 113 | 11 weeks | 46/55 | 3 days |
Note. MINORS = Methodological Index for Non-Randomized Studies; ORIF = open reduction internal fixation; CRPP = closed reduction percutaneous pinning; ROM = range of motion; UNK = Unknown.